Elevated Urine N Acetylaspartic Acid Level C5826558
A finding often associated with Canavan disease, a rare genetic condition causing progressive neurological symptoms. Management focuses on supportive care.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Developmental delay
(neurologic)Hypotonia
(neurologic)Macrocephaly
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive supportive care and monitoring
Regular monitoring of neurological status, growth parameters, and nutritional intake to address the progressive nature of Canavan disease. Multidisciplinary care involving neurologists, nutritionists, and developmental specialists.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Additional treatment options
Seizure management
Anticonvulsant medications to control seizure activity that commonly occurs in Canavan disease patients. Regular monitoring of seizure frequency and medication effectiveness.
medicationPhysical and occupational therapy
Therapeutic interventions to maintain joint mobility, prevent contractures, and support functional abilities. Focus on positioning, stretching, and adaptive techniques for daily activities.
physical_therapyNutritional support and management
Specialized nutritional interventions including gastrostomy tube feeding when oral intake becomes insufficient. Regular assessment of caloric needs and hydration status.
dietaryExperimental and gene therapy trials
Participation in clinical trials investigating gene replacement therapy and other novel treatments for Canavan disease. Requires evaluation at specialized research centers.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Elevated Urine N Acetylaspartic Acid Level C5826558?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Elevated Urine N Acetylaspartic Acid Level C5826558. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy